Treffen Media
Aseptic Processing Workshop
Date: 9th April 2026
Venue: Novotel Hyderabad Airport
Register
Workshop
Maintaining compliant quality standards are not only profitable but also mandatory…
Why
Why Treffen Media’s Aseptic Processing Workshop will help you up your aseptic processing game
Trainer
Dr. Andrew Hopkins, Senior Director, Lachman Consultants and Senior Director at Lachman Consultants
About the workshop
Poor aseptic behavior not only leads to warning letters but also import bans indicating that inspite of drug shortages the importing countries are not willing to compromise on FDA and CGMP Standards especially where there are repeat observations. Maintaining compliant quality standards are not only profitable but also mandatory as remediation is not only expensive but also a requisite.
In the recent past, regulators are also extremely stringent regarding sterile products as even minor lapses in aseptic processing can compromise patient safety greatly. An analysis of recent sterile warning letters clearly shows a gap between sterility expectations of global regulators and current industrial practices.
Understanding the need to bridge this gap, Treffen Media has collaborated with Dr. Andrew Hopkins, former GMDP Inspector at the UK’s (MHRA), to bring you a one-day comprehensive training on Aseptic Processing on the 9th of April 2026 in Hyderabad, India
Here are top 5 reasons why Treffen Media’s Aseptic Processing Workshop in Hyderabad on the 9th April 2026 will help you up your aseptic processing game
Training topics are curated from the most frequently cited sterile observations from the USFDA, ensuring direct alignment with real-world regulatory expectations and aseptic standards
The program is led by Andrew Hopkins, who chaired the Annex 1 revision working group at the Medicines and Healthcare products Regulatory Agency (MHRA) who has designed a workshop that incorporates theoretical and interactive methodologies.
With senior leadership experience at AbbVie and first-hand service of over 14 years as an MHRA inspector, Mr. Hopkins delivers a rare blend of industry insight and regulatory authority, translating compliance requirements into practical, implementable strategies.
Detailed Case studies under each topic to give you actionable insights, regulatory implications and relevant remedies.
Engaging modules on Media Fills, Smoke Studies , Annex 1 and Environmental Monitoring to focus on key problem areas in aseptic processing.
About the Trainer
Dr. Andrew Hopkins
Senior Director, Lachman Consultants and Senior Director at Lachman Consultants & Former GMDP Inspector at the UK’s Medicines and Healthcare products Regulatory Agency (MHRA)
- 14 years’ experience as a GMDP Inspector at the UK’s (MHRA)
- Played a pivotal role in modernizing Annex 1 of the EU GMP for sterile medicinal products, initiating the revision process and drafting the first consultation document in collaboration with EMA and PIC/S regulators
- Serves on the Board of Directors of the Parenteral Drug Association (PDA) and has participated in technical report working groups (TR1, TR13, TR90).
- In Industry, He held senior leadership roles in AbbVie and established and led a global microbial contamination control group focused on contamination control strategy, facility design, environmental monitoring, and operational excellence
- Contributions extend to the development of good practice guidance for blood transfusion and blood products across the EU and also Part IV of EU GMP for ATMPS.
- Currently he is a Senior Director at Lachman Consultants and one of the pharmaceutical industry’s most respected experts in GMP compliance, sterile manufacturing, and microbial contamination control